Prevention

Respiratory Syncytial Virus is an incredibly common virus that hits both the very young and the very old disproportionately.

The US Food and Drug Administration (FDA) has released a consumer update encouraging participation as well as diversity within clinical trials.

In light of recent news that reported “vaccine skeptic,” Robert F. Kennedy, may be appointed to lead president-elect Donald Trump’s panel on vaccine safety, Contagion spoke with vaccine experts to learn of any potential ramifications this may have.

New research finds that RNA expression may be the key to diagnosing bacterial infections in infants.

In response to the increasing number of syphilis cases reported in Japan, the Japanese government is launching a prevention campaign that will include Sailor Moon as a spokesperson for sexual education.

A new biotechnology company, Vir Biotechnology, is gunning for bear in the fight against infectious diseases and boasting a roster of heavy hitters in the industry.

The 2016-2017 influenza season continues to see a growing number of severe flu cases due to the increased prevalence of influenza A (H3N2) virus.

Researchers from the University of Bristol have revealed the structural and mechanistic basis of transferable colistin resistance conferred by the MCR-1 gene.

Researchers at Southern Research Institute are focusing their efforts on finding a broad-spectrum antiviral drug that will be effective against a number of influenza strains.

The H3N2 strain of influenza continues to circulate throughout Calgary, as well as in the South Zone, while “little influenza activity in the North Zone [has been observed] to date.”

Elizabeth Nolan, PhD, and her team at the Massachusetts Institute of Technology, recently explored the fight between microbes and hosts over essential metals and how understanding this battle may open the door for alternate treatments for bacterial infections.

Researchers have found no link between an influenza infection during pregnancy and an increased risk of an autism spectrum disorder diagnosis.

Researchers have conducted a study looking into the role that vitamin D might play in reducing the number of acute respiratory infections that are experienced by older adults residing in long-term care facilities.

University of Connecticut researchers have developed novel antibiotic compounds to target methicillin-resistant Staphylococcus aureus infections, offering a potential new drug in the fight against this pathogen.

Dutch scientists have identified the best conditions for Legionella growth: conditions that support biofilm growth.

A new report finds that real-time patient-centered research is possible during an outbreak, and indeed, necessary to strengthen systems, improve surveillance and response, and create better diagnostics, therapeutics and vaccines.

As adults are living longer, they are able to continue to have healthy sex lives. Unfortunately, many are not practicing safe sex, and healthcare practitioners are not screening their older patients for sexually transmitted diseases (STDs).

Researchers uncover high rates of co-infections in patients who are admitted to hospitals with influenza.

A research team examines two Yosemite plague diagnoses to determine effectiveness of procedures for the detection, protection, and prevention of Yersinia pestis.

Seeking to improve the nation’s health and safety, the Centers for Disease Control and Prevention (CDC) has been targeting several high-burden issues in which it could make the greatest impact, and three such issues are infectious diseases.

With cases of antibiotic-resistant gonorrhea on the rise, researchers from the University of York may have made a breakthrough in the quest to find treatments that work.

New surveillance reports from the Centers for Disease Control and Prevention (CDC) show that this year’s influenza vaccine can offer effective protection against circulating viruses this flu season.

Research on a patient with acute myeloid leukemia has revealed new information on how bacteria mutate to survive antibiotics.

With the opening of a new R&D center in Rockville, MD, GlaxoSmithKline strives to improve global outbreak preparedness and calls for increased vaccine production capacity.

A new coalition created by the Bill & Melinda Gates Foundation and other global partners will launch at this year’s World Economic Forum, with the goal of supporting the fast-tracked development of new vaccines.